Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptomic analysis of glioblastoma cells bearing different IRE1a mutants

ABSTRACT: Transcriptomic analysis of glioblastoma cells bearing different IRE1a mutants

PROVIDER: PRJNA421725 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Transcriptomic analysis of glioblastoma cells bearing different IRE1a mutants

Project description:Glioblastoma multiforme is the most lethal form of glioma with an overall survival at 5 years nearly null, which mainly results from acquired resistance to therapies. Large scale sequencing studies on human cancer biopsies defined IRE1alpha as the fifth most oncogenic mutated kinase in human cancer. IRE1alpha is a major component of the Unfolded Protein Response signaling and increasing evidence suggests that it is a central player in GBM development.

2017-12-09 | GSE107859 | GEO

Transcriptome profiles of different light-signaling mutants

Project description:Transcriptome profiles of different light-signaling mutants

| PRJNA688924 | ENA

Sequencing of different Actinoplanes sp. SE50/110 mutants

Project description:Sequencing of different Actinoplanes sp. SE50/110 mutants

| PRJEB12637 | ENA

Spatial transcriptomics of brains from tumor-bearing C57BL/6 mice

Project description:GL261-derived glioblastoma stem cells (GSCs) form aggressive tumors when implanted into the brains of C57BL/6 mice. We used spatial transcriptomics to analyze brain sections of tumor-bearing C57BL/6 mice at 28 days post-implantation

2024-03-28 | GSE245263 | GEO

Microarray analysis of differentiation of human glioblastoma stem cells

Project description:Glioblastoma multiforme is one of the most devastating cancers and presents unique challenges to therapy due to its aggressive behaviour. Cancer stem cells have been described to be the only cell population with tumorogenic capacity in glioblastoma. Therefore, effective therapeutic strategies targeting these cells may be beneficial. We have established different cultures of glioblastoma stem cells (GSCs) derived from surgical specimens and found that, after induction of differentiation, NFκB was activated, which allows intermediate tumor precursor cells to remain cycling. We also showed that blockade of NFκB signaling in differentiating GSCs by different genetic strategies or treatment with small molecule inhibitors, promoted replication arrest, progression to a mature phenotype, mainly neuronal cells, and senescence. This effect was partly mediated by downregulation of the NFκB target gene cyclin D1. Furthermore, intravenous treatment of immunodeficient mice bearing human GSC-derived tumors with a novel small-molecule inhibitor of the NFκB pathway induced senescence of tumor cells but no ultraestructural alterations of the brain parenchymal cells were detected. These findings reveal that activation of NFκB may keep differentiating GSCs from acquiring a mature postmitotic phenotype, thus allowing cell proliferation, and support the rationale for therapeutic strategies aimed at promoting premature senescence in GSCs undergoing differentiation. Gene expression in differentiated cells relative to stem cells in three different glioblastoma cultures

2011-03-01 | E-GEOD-20736 | biostudies-arrayexpress

Functional properties of PTEN and PTEN mutants in U87MG glioblastoma cells

Project description:To investigate the effects of PTEN activity on gene expression in 3D cultured glioblastoma cells and the contributions of PTEN's lipid and protein phosphatase activities to these effects. We expressed wild type PTEN, a catalytically dead mutant (C124S) or mutants selectively lacking protein or lipid phosphatase activity (Y138L and G129E respectively) in U87MG cells at physiological levels by transient unselected polyclonal lentiviral transduction. Cells were then seeded into 3D matrigel and RNA prepared after 15 hours.

2012-02-28 | E-MTAB-989 | biostudies-arrayexpress

Impact on Glioblastoma U87 Cell Gene Expression of a Carborane Cluster-bearing Amino Acid

Project description:Impact on Glioblastoma U87 Cell Gene Expression of a Carborane Cluster-bearing Amino Acid

| PRJNA491491 | ENA

Transcriptional profiles on different yeast strain mutants

Project description:Transcriptional profiles on different yeast strain mutants (DEgd2/1, DEgd2/Btt1)were identified by microarray analysis comparing total mutant RNA vs wild type RNA.

2013-04-05 | GSE45796 | GEO

To find out different expression lncRNAs between glioblastoma cancer and adjacent normal glioblastoma tissue

Project description:To further understand the molecular mechanisms in the development of glioblastoma cancer, we employed this microarray to identify lncRNAs associated with glioblastoma cancer.

2016-06-21 | GSE83511 | GEO

Impact on Glioblastoma U87 Cell Gene Expression of a Carborane Cluster-bearing Amino Acid

Project description:Treatment with carborane bearing amino acid on U87 cells showed cytostatic effect followed by cell death. We used microarrays to investigate the effect of the carborane bearing amino acid on U87 cell gene expression profile and explore the mechanism.

2020-09-30 | GSE120066 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data